{"id":"W4401435959","doi":"10.1093/bjd/ljae266.067","title":"693 - Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Placebo; Atopic dermatitis; Internal medicine; Tolerability; Apremilast; Population; Clinical endpoint; Psoriasis; Randomized controlled trial; Gastroenterology; Clinical trial; Adverse effect; Immunology; Disease; Psoriatic arthritis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006847088,0.0002355327,0.002288416,0.0004816733,0.00007872928,0.00007199712,0.0001171352,0.000395428,0.00007052517],"category_scores_gemma":[0.0004607241,0.0001880958,0.0004049526,0.0003338266,0.0003236461,0.0001873867,0.00004308928,0.001125245,0.000008692],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004994111,"about_ca_system_score_gemma":0.0006693738,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004650299,"about_ca_topic_score_gemma":0.00005391222,"domain_scores_codex":[0.9958919,0.0006023321,0.002503036,0.0003081342,0.00034975,0.0003448865],"domain_scores_gemma":[0.9976342,0.00113005,0.0004324097,0.0001496751,0.0002777498,0.0003758583],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9733914,0.001163815,0.0001370575,0.0001361897,0.002178079,0.01536091,0.0004955762,0.00005873512,0.00001470123,0.0002531417,0.001052393,0.005757974],"study_design_scores_gemma":[0.8943296,0.00132206,0.0001958765,0.003980228,0.002104473,0.09567204,0.0001534284,0.001636607,0.00008068878,0.0001514102,0.0002062449,0.0001673504],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9816228,0.007685654,0.001727164,0.004764083,0.0007166047,0.003041941,0.00002057562,0.0000289127,0.000392261],"genre_scores_gemma":[0.9957219,0.002952593,0.0005373145,0.0002810671,0.0003031388,0.00009349379,0.00001730409,0.00003154905,0.00006161493],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08031113,"threshold_uncertainty_score":0.7670323,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01806843697846072,"score_gpt":0.3136291326597535,"score_spread":0.2955606956812928,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}